Lantern Pharma Announces Collaboration with World Leading Brain Cancer Program at Johns Hopkins to Further Develop LP-184 as Therapy for Glioblastoma

Written By Health Wildcatters
Health Wildcatters
Previous

Executive Holidays: Cynt Marshall, Chad Houser, Chris Kelly, Peter Brodsky, and More
Next

Health Wildcatters portfolio company LocuMatch relocates to McKinney